Bluebird Bio

The pharmaceutical market is notoriously difficult to predict. Drug developers and the analysts who cover them must navigate a landscape shaped by geopolitical shifts, financial pressures and regulato

Thirty-three states plus the District of Columbia and Puerto Rico committed to adopting standardized utilization management policies for at least one of the gene therapies for sickle cell disease on t

While cuts to Medicaid under the recent budget bill have been grabbing the most headlines, the Centers for Medicare and Medicaid Services is also heralding progress in implementing a Medicaid program

Bluebird bio announced new leadership appointments following its acquisition by two private equity firms – Carlysle and SK Capital Partners – in June. The now-private company already announced the app